Filing Details

Accession Number:
0000905718-14-000723
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-10-31 20:43:01
Reporting Period:
2014-10-29
Filing Date:
2014-10-31
Accepted Time:
2014-10-31 20:43:01
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1551693 Sientra Inc. SIEN Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842) 205551000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1397144 Llp Abingworth 38 Jermyn Street
London X0 SW1Y 6DN
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2014-10-29 495,000 $15.00 2,199,012 No 4 P Indirect See Notes
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect See Notes
Footnotes
  1. These shares were purchased in connection with the Issuer's initial public offering of Common Stock.
  2. Consists of (i) 247,500 shares held of record by Abingworth Bioventures V LP, or ABV V, and (ii) 247,500 shares held of record by Abingworth Bioventures V Co-Invest Growth Equity Fund LP, or AGE. ABV V and AGE are collectively referred to as the "Abingworth Funds." The investment manager of the Abingworth Funds is Abingworth LLP, or Abingworth. Abingworth Bioventures V GP LP, or Abingworth GP, a Scottish limited partnership, serves as the general partner of each of the Abingworth Funds.
  3. Abingworth General Partner V LLP, a Scottish limited liability partnership, serves as the general partner of Abingworth GP. Abingworth GP (acting by its general partner Abingworth General Partner V LLP) has delegated to Abingworth all investment and dispositive power over the shares held by the Abingworth Funds. The reporting person holds the reported securities indirectly through the Abingworth Funds.
  4. The reporting person disclaims beneficial ownership of such shares, except to the extent of its pecuniary interest therein. This report shall not be deemed an admission that the reporting person, the Abingworth Funds or any other person is the beneficial owner of the securities reported herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.